SE ID | SE Region | Sample ID | Tissue type | Biosample name | SE rank | Element | Common SNP | eQTL | Risk SNP | TFBS | CRISPR Cas9 | Gene |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SE_02_152400018 | chr12:75922202-76051296![]() |
Sample_02_1524 | Lung | H3122 DMSO | 18 | 33 | 3451 | 102 | 16 | 380 | 1115 | NAP1L1,PHLDA1 |
SE_02_101700056 | chr12:75933039-76085756![]() |
Sample_02_1017 | Embryo | H9_Mesendoderm 24h_Hydroxyurea | 56 | 34 | 3961 | 104 | 21 | 440 | 1570 | NAP1L1,PHLDA1 |
SE_02_044200114 | chr12:75969856-76048903![]() |
Sample_02_0442 | Bone | MG63.3 | 114 | 34 | 2157 | 66 | 9 | 248 | 1030 | PHLDA1,NAP1L1 |
SE_02_030100115 | chr12:75974016-76049231![]() |
Sample_02_0301 | Neuroblastoma | GIMEN | 115 | 8 | 2034 | 64 | 9 | 241 | 1042 | NAP1L1,PHLDA1 |
SE_02_151100060 | chr12:75974472-76052557![]() |
Sample_02_1511 | Lung | H3122_untreated | 60 | 25 | 2094 | 67 | 10 | 263 | 1115 | NAP1L1,PHLDA1 |
SE_02_029400100 | chr12:75975226-76049001![]() |
Sample_02_0294 | Pancreatic | L3-6_DMSO | 100 | 6 | 1997 | 63 | 9 | 231 | 1030 | NAP1L1,PHLDA1 |
SE_02_081100060 | chr12:75976126-76048712![]() |
Sample_02_0811 | Thyroid | BCPAP | 60 | 16 | 1976 | 63 | 9 | 231 | 1030 | PHLDA1,NAP1L1 |
SE_02_047400382 | chr12:75996456-76046935![]() |
Sample_02_0474 | Fibroblast | umbilical cord Fibroblast | 382 | 13 | 1392 | 43 | 7 | 163 | 921 | PHLDA1,NAP1L1 |
SE_02_017200108 | chr12:76010310-76086827![]() |
Sample_02_0172 | Lung | IMR-90_quiescent | 108 | 8 | 1922 | 36 | 12 | 228 | 1570 | NAP1L1,PHLDA1 |
SE_02_065900065 | chr12:76011208-76085797![]() |
Sample_02_0659 | Lung | H23 | 65 | 24 | 1866 | 35 | 11 | 210 | 1570 | NAP1L1,PHLDA1 |
SE_02_048100066 | chr12:76014484-76087069![]() |
Sample_02_0481 | Mammary gland | MDA-MB231 | 66 | 23 | 1770 | 36 | 11 | 211 | 1570 | NAP1L1,PHLDA1 |
SE_02_127800414 | chr12:76015231-76050031![]() |
Sample_02_1278 | Chordoma | UCH1_DMSO_48h | 414 | 7 | 865 | 16 | 1 | 149 | 1079 | NAP1L1,PHLDA1 |
SE_02_083000182 | chr12:76015576-76047924![]() |
Sample_02_0830 | Lung | H1703 SMARCA2-infected | 182 | 5 | 810 | 15 | 1 | 117 | 990 | PHLDA1,NAP1L1 |
SE_02_082900233 | chr12:76015590-76047558![]() |
Sample_02_0829 | Lung | H1703 SMARCA4-infected | 233 | 8 | 802 | 15 | 1 | 108 | 964 | PHLDA1,NAP1L1 |
SE_02_104902068 | chr12:76016671-76064132![]() |
Sample_02_1049 | Peripheral blood | CD4+ cell_ROMI | 2068 | 14 | 1168 | 26 | 4 | 175 | 1278 | NAP1L1,PHLDA1 |
SE_02_126500730 | chr12:76017128-76049418![]() |
Sample_02_1265 | Bone | Im-GCT-4072_G34W-repair_WT_D6 | 730 | 6 | 788 | 15 | 1 | 133 | 1054 | NAP1L1,PHLDA1 |
SE_02_053100026 | chr12:76017469-76052626![]() |
Sample_02_0531 | Mammary gland | MDA-MB-231 | 26 | 13 | 863 | 19 | 2 | 150 | 1115 | NAP1L1,PHLDA1 |
SE_02_042000150 | chr12:76020129-76048243![]() |
Sample_02_0420 | Pectoralis major muscle | LHCN-M2_dox_6h | 150 | 8 | 691 | 15 | 0 | 106 | 1006 | NAP1L1,PHLDA1 |
SE_02_026000518 | chr12:76067263-76086880![]() |
Sample_02_0260 | Lung | NCI-H1299_EGFP-NEO_reporter_cells_SB939 | 518 | 5 | 456 | 7 | 7 | 36 | 285 | NAP1L1,PHLDA1 |
SE_02_042200377 | chr12:76067288-76086967![]() |
Sample_02_0422 | Lung | NCI-H1299_EGFP-NEO_reporter_cells_DACSB | 377 | 5 | 456 | 6 | 7 | 36 | 283 | NAP1L1,PHLDA1 |
SE_02_113901177 | chr12:76068238-76086215![]() |
Sample_02_1139 | Retinal Pigmented Epithelial | RPE1-anaphase/telophase | 1177 | 3 | 417 | 5 | 6 | 31 | 253 | NAP1L1,PHLDA1 |
SE_02_113800921 | chr12:76068461-76086120![]() |
Sample_02_1138 | Retinal Pigmented Epithelial | RPE1-prometaphase | 921 | 5 | 411 | 5 | 6 | 31 | 253 | NAP1L1,PHLDA1 |
SE_02_143300845 | chr12:76071301-76085742![]() |
Sample_02_1433 | Bone | A673 STAG2 null | 845 | 4 | 337 | 5 | 4 | 26 | 222 | NAP1L1,PHLDA1 |
SE_02_061700720 | chr12:76074500-76086937![]() |
Sample_02_0617 | HSPC | FL CD34+CD38-/lowCD90+ HSPC | 720 | 3 | 288 | 6 | 3 | 24 | 205 | NAP1L1,PHLDA1 |
SE_02_044700161 | chr12:76080481-76085758![]() |
Sample_02_0447 | Lung | lung metastasis from primary osteosarcoma tumor M2 | 161 | 2 | 119 | 4 | 2 | 23 | 205 | NAP1L1,PHLDA1 |
SE_02_067300452 | chr12:76080853-76120091![]() |
Sample_02_0673 | Prostate | LNCAP_FA | 452 | 13 | 1060 | 29 | 4 | 41 | 205 | NAP1L1,PHLDA1 |
SE_02_060900056 | chr12:76082663-76085806![]() |
Sample_02_0609 | Liposarcoma | LPS141 | 56 | 1 | 76 | 2 | 2 | 22 | 205 | NAP1L1 |
SE_02_044600199 | chr12:76082772-76085771![]() |
Sample_02_0446 | Bone | osteosarcoma tumor P2 | 199 | 1 | 74 | 2 | 2 | 22 | 205 | NAP1L1 |
SE_02_061600022 | chr12:76082812-76086672![]() |
Sample_02_0616 | Liposarcoma | liposarcoma cells_LP6 | 22 | 1 | 94 | 3 | 3 | 23 | 205 | NAP1L1 |
SE_02_137200475 | chr12:76083021-76085388![]() |
Sample_02_1372 | Pancreas | PSN1-untreated | 475 | 1 | 63 | 2 | 2 | 19 | 205 | NAP1L1 |
SE_00_001001093 | chr12:76083297-76086609![]() |
Sample_00_0010 | Embryo | endodermal-cell | 1093 | 1 | 82 | 3 | 2 | 23 | 205 | NAP1L1 |